Terms: = Brain cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Staging
5 results:
1. Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer.
Wegen S; Claus K; Linde P; Rosenbrock J; Trommer M; Zander T; Tuchscherer A; Bruns C; Schlößer HA; Schröder W; Eich ML; Fischer T; Schomäcker K; Drzezga A; Kobe C; Sabine Roth K; Weindler JJ
Radiat Oncol; 2024 Apr; 19(1):44. PubMed ID: 38575990
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical implication of BRSK2 expression in pancreatic ductal adenocarcinoma].
Niu GM; Ji Y; Jin DY; Hou J; Lou WH
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1084-8. PubMed ID: 20646422
[TBL] [Abstract] [Full Text] [Related]
3. Malignant salivary gland tumors in Quito, Ecuador.
Pacheco-Ojeda L; Domeisen H; Narvaez M; Tixi R; Vivar N
ORL J Otorhinolaryngol Relat Spec; 2000; 62(6):296-302. PubMed ID: 11054011
[TBL] [Abstract] [Full Text] [Related]
4. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.
Sternberg CN; Yagoda A; Scher HI; Watson RC; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N; Weiselberg LR
J Urol; 1988 Mar; 139(3):461-9. PubMed ID: 3343727
[TBL] [Abstract] [Full Text] [Related]
5. Magnetic resonance imaging of the genitourinary tract.
LiPuma JP; Bryan PJ; Butler HE; Resnick MI
Urol Clin North Am; 1986 Aug; 13(3):531-50. PubMed ID: 3523930
[TBL] [Abstract] [Full Text] [Related]
